However it’s our case, so the Reed Smith side can’t comment on it … period. Maybe the Dechert side will. All we can do at this time is provide our readers with a link to the opinion.
Yes, We Know About Stengel
The definitive source for intelligent commentary on the law that matters for drug and device product liability cases